News | April 22, 2015

Higher field strength improves image quality but raises concerns about radiation dose to the fetus

April 22, 2015 — Although ultrasound remains the primary imaging modality used in prenatal imaging, fetal magnetic resonance imaging (MRI) is playing an increasing role in further evaluation of fetuses suspected of congenital anomalies. As 3-T MRI scanners become more common due to their improved image signal-to-noise ratio and anatomical detail, the benefits of 3-T MRI must be weighed against potential risks to the fetus that may result from the higher field strength.

"MRI is playing an increasingly important role in the assessment of complex prenatal disease," said Kathleen E. Carey, M.D., Mayo Clinic, Jacksonville, Florida. "The use of stronger 3-T field strengths may allow for improved visualization of subcutaneous fat and osseous structures, including the hands and feet of the developing fetus."

The study is featured in an electronic exhibit at the American Roentgen Ray Society (ARRS) 2015 annual meeting in Toronto.

First attempted in the 1980s, MRI in pregnancy has maintained a steady growth rate. Recent studies have demonstrated that fetal MRI not only provides good detail of normal fetal anatomy and allows characterization of suspected anomalies but also may alter the diagnosis provided by ultrasound, uncovering fetal anomalies earlier and more accurately. Currently, clinical MRI is most frequently performed on 1.5-T MRI systems, but 3-T scanners are becoming more common around the world as the search for improved image signal-to-noise ratio and anatomic detail grows. This developmental opportunity must be weighed against potential risks to the fetus, taking into account the specific absorption rate.

ARRS will present a series of fetal MRI cases and discuss the anatomic and imaging findings, indication for MRI, diagnosis and impact on patient management. The benefits and limitations of fetal MRI at 1.5-T and 3-T field strengths will be discussed, and future advanced imaging will be considered, including spectroscopy and diffusion tensor imaging.

For more information: www.arrs.org


Related Content

News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | FDA

March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...

Time March 27, 2024
arrow
News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Artificial Intelligence

December 22, 2023 — Quibim, a company pioneering imaging biomarkers for Precision Medicine that has created AI-based ...

Time December 22, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

December 20, 2023 — Terran Biosciences, Inc., a biotech platform company developing therapeutics and technologies for ...

Time December 20, 2023
arrow
Subscribe Now